drugset / Trial / NCT02701348

Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers

NCT02701348

Completed 31 enrolled NHS Tayside
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to monitor the change in cancer size in women with breast cancer on anti-hormone treatment using different types of assessment including ultrasound scan (US), shearwave elastography (SWE) and magnetic resonance imaging (MRI), and assess how this corresponds to the changes in the cancer biology.

Timeline

Start
2016-05
Primary completion
2020-12-24
Completion
2020-12-24

Drugs

EvaluationDrugModalityDoseRoute
Background Letrozole Other / unclassified

Indications